Advanced Breast Cancer
09
Sep
An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination with Pembrolizumab Versus Treatment of Physic...
Early Breast Cancer
23
Jul
Elacestrant versus Standard Endocrine Therapy in Women and Men with Node positive, Estrogen Receptor positive, HER2-negative, Early B...